\
&
Contact us
Published on | 54 minutes ago
ProgrammesThe updated version of the Horizon Europe Work Programme (HE WP) 2026-2027 Research Infrastructures (RI) was published on 29 September 2026 (available here). An overview of the changes compared to the previous version (1.0 with publication date 11 December 2025, available here) is the subject of this article.
In the introduction reference is now made to the HE Horizontal Activities work programme (HA WP) which also includes call topics relevant to the areas covered in the RI work programme. The Bridging Actions 2027 call included in the HA WP aims to prepare the ground for the EU's next research and innovation programme, Horizon Europe 2028-2034, and its links with the future European Competitiveness Fund. The three call topics related to RI areas are:
The total call topic budget for HORIZON-INFRA-2027-DEV-01-01 Preparatory phase of new ESFRI research infrastructure projects has been reduced from €30 to €29 million. The expected EU contribution per project remains unchanged, between €1.5 and €3.5 million. The €1 million reduction was used to create a new action under the HA WP: HORIZON-RAISE-2027-01-04 Developing a model for a Data Lab for Science linking with EOSC and RAISE (RAISE pilot) (CSA).
The total call topic budget for HORIZON-INFRA-2027-DEV-01-03 Consolidation of the research infrastructure landscape – individual support for evolution, long-term sustainability and emerging needs of pan-European research infrastructures has been reduced from €29.50 to €29.35 million. The expected EU contribution per project remains unchanged, between €3 and €4.5 million. A new Grant to Identified Beneficiary (GIB) of €0.15 million to support the organisation of the 25-year anniversary of the ESFRI conference under the Greek Presidency (1 July-31 December 2027) has been added.
There have been amendments to the description to clarify the FSTP approach in two call topics under destination INFRASERV:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.